Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Halia Therapeutics announced it raised $3.49 Million in an initial filing from an offering of $20 Million
PRIVATEAug 31, 2026•6 days ago
Amount Raised
$3.49 Million
Round Type
Venture - Series Unknown
LehiBiotechnology
Company Information
Company
Halia Therapeutics
Location
3900 N. Traverse Mountain Blvd
Lehi, Utah, United States
About
Halia is a clinical-stage biopharmaceutical company discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases.
We do this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses.
Don't miss Halia Therapeutics's next move
Get an email the moment Halia Therapeutics raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contacts hidden hidden hidden hidden
Predictive Intelligence
Strategic
ML-powered predictions for Halia Therapeutics's next move